LIV Emles at Home ETF

Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its shareholders are invited to the Annual Shareholders Meeting on Wednesday, May 31, 2006 10 a.m. at the Sterling Club, Turnberry Towers, 2827 Paradise Rd., Las Vegas, Nevada. Additionally, Samaritan will host an "open house" reception for its shareholders on May 30, 2006, the evening before, from 5 p.m. to 7 p.m. at its expanded corporate offices 101 Convention Center Dr. Ste. 310, Las Vegas, NV. Samaritan will also informally present an in-depth view of its innovative drug pipeline for interested shareholders. Samaritan Pharmaceuticals: "We LIV....to Save Lives." Samaritan is a small-cap Biotech, driven to discover, develop and commercialize innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease patients. Look at www.samaritanpharma.com. Please register on Website so we can notify you of upcoming conference calls, news and events. Disclaimer The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Website. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed April 15, 2005. The company undertakes no duty to update forward-looking statements.